Albert David peers

Companies like Albert Davidlatest year

Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

ALBERTDAVD₹772.00

Albert David Limited

· Pharma & Health
₹ CrorePeersVALIANTLABHALEOSLABSZIMLABMEDICOMEDICAMEQANUHPHRAHCLWANBURYMcap ₹441 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
ALBERTDAVD
FY26
VALIANTLAB
FY26
HALEOSLABS
FY26
ZIMLAB
FY26
Peer
Average
Valuation — at last close
P/E——◆ 25.33×118.71×72.02×
P/B◆ 1.13×2.20×2.05×2.55×2.27× -50%
EV/EBITDA38.64×108.79×◆ 12.56×27.83×49.73× -22%
Market Cap₹441 Cr₹683 Cr₹439 Cr₹756 Cr₹626 Cr -30%
Growth
Revenue CAGR 3Y-0.78%—◆ 1.89%-2.06%-0.09% -818%
Revenue CAGR 5Y◆ 6.16%—4.68%—4.68% +32%
Net Income CAGR 3Y——◆ 16.09%-37.95%-10.93%
Revenue YoY (latest Q)43.60%◆ 146.22%-11.59%31.25%55.29% -21%
Net Income YoY (latest Q)303.12%◆ 1058.93%-58.00%-114.25%295.56% +3%
Profitability
EBITDA Margin1.64%2.69%◆ 13.38%8.02%8.03% -80%
Net Income Margin-0.45%-1.38%◆ 5.33%1.56%1.84% -125%
Return on Common Equity-0.38%-1.20%◆ 8.44%2.13%3.12% -112%
Return on Capital Employed-1.06%0.10%◆ 10.70%3.06%4.62% -123%
Return on Assets-0.29%-0.76%◆ 4.22%1.15%1.54% -119%
Credit & Quality
Total Debt/Equity◆ 0.07×0.14×0.47×0.42×0.34× -80%
Interest Coverage-1.63×0.18×◆ 4.53×0.76×1.82× -189%
Scale — latest FY
Revenue / Total Income₹334 Cr₹237 Cr₹334 Cr₹374 Cr₹315 Cr +6%
Net Income−₹1.5 Cr−₹3.3 Cr₹17.8 Cr₹5.8 Cr₹6.8 Cr -122%
Total Assets₹519 Cr₹464 Cr₹454 Cr₹539 Cr₹486 Cr +7%
EPS₹-2.62₹-0.51₹57.26₹1.19₹19.31 -114%
Book Value per Share₹686.04₹57.24₹706.34₹55.36₹272.98 +151%
◆ best value in the comp set per metric · Δ = subject vs average of the other companies.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.